Shield Therapeutics Share Discussion Threads

[reviewwworld] 25/4/2024 13:21

Re the buyers... Given company history, this is an extremely high risk investment that is either on the "punt" side of things or a major shareholder is averaging down and relentlessly believes the story can be turned around.It's a value trap here and all about balance of probabilities. This forum is filled with endless hope about the wonderful product and what it COULD achieve. I get all that, hence I invested. But when you're in a death spiral of seemingly endless dilution and consistent horrendous corporate strategy, you'd be ignorant to buy it solely on the merit of it's one product (that is a ticking time bomb re patent life albeit a long one).What we've got here is Michael Phelps living in the middle of the desert.

[qipincha] 25/4/2024 12:49

Don’t think it still makes sense to do fund raising, more realistic with short term borrowing if they need. This is something I am hoping to find out from their update.

[bos1234] 25/4/2024 12:26

Reviewworld, so who do you think are buying all the shares that are being sold and why are they buying them?

[weatherman] 25/4/2024 12:20

Are we looking at 2 for 1 dilution at 1p ? :( - hope not, but not looking good.

[qipincha] 25/4/2024 12:20

I don’t think share price is always a good indicator, especially for SMEs, the price can be easily manipulated.

[reviewwworld] 25/4/2024 12:09

The share price sadly indicates otherwise.If there is one thing we have learnt about this sinking ship is that it's a very leaky one. Every single announcement by the company of the past 2 years has seen selling beforehand that has proven to be "smart" sales.This move today, in decent volume, just confirms the narrative. Every announcement I report to the FCA for insider dealing but yet to receive a response/investigation.Regardless, don't be surprised when the 30th comes with even more value destruction for us retail investors

[bos1234] 25/4/2024 11:48

It takes hundreds of millions of dollars to bring a new drug to the market. Shield has rights to the IPR protected until 2035. Has launched the product and has a rapidly expanding market. Has major shareholders who have invested millions and millions of dollars into this company. I do not know what will happen in the next 12 months but I think it is inconceivable that the major shareholders will shrug their shoulders, walk away and let it go bankrupt.

[ih_676530] 25/4/2024 11:09

The share price is heavily oversold on the tech chart,especially after today's drop. This should draw in value and chart traders. If Tuesday's results are as good as February's trading update then the share price could easily double in value in a single day.

[qipincha] 25/4/2024 10:56

This is already known. Nothing new

[tripletop1] 25/4/2024 10:50

all started with the insider selling ahead of the fundraise when the share price was at 12.5p end Sept.

that should have been the moment to bail..

[r9505571] 25/4/2024 08:00

Consensus revenue estimates fall by 19%The consensus outlook for revenues in fiscal year 2023 has deteriorated.2023 revenue forecast decreased from US$15.3m to US$12.4m.Forecast losses increased from -US$0.037 to -US$0.039 per share.Pharmaceuticals industry in the United Kingdom expected to see average net income growth of 37% next year.Consensus price target down from UK£0.15 to UK£0.02.Share price fell 3.7% to UK£0.014 over the past week.

[cordwainer] 24/4/2024 16:07

Re review world, conversation = "let's make a lowball offer for the rest of the shares which this weak and shareholer unfriendly mgmt will accept and who cares about the small retail shareholders.. "

[reviewwworld] 24/4/2024 15:29

If you're the major shareholder, I wonder what conversation you're having internally

[best1467] 24/4/2024 15:00

Well Scott I would be extremely happy to be 90% down here.Would love nothing more than to be completely wrong but this CEO has been worse than the previous which seemed impossible

[reviewwworld] 24/4/2024 10:34

From day 1 I assigned zero value to Edison research. I mean, STX pay them to write it. It's like asking your best mate to write your school report. Mad that such a thing exists, sad that such a thing is permitted by the FCA.

[cordwainer] 24/4/2024 00:57

re weatherman - of course, makes more sense than my mini-rant.

[razoblade] 23/4/2024 19:19

Edison wrong, misled or exaggerated the research. Surly if the company starts to miss quarterly figures and you keep egging it on, you are partly to blame as investors use such research papers to get some insight into the business.

[weatherman] 23/4/2024 13:48

It means STX are cutting costs to the bone.

[cordwainer] 23/4/2024 13:41

Edison announced terminating coverage along with a clutch of other small companies. Possibly because they know they were wrong.

[best1467] 22/4/2024 13:13

The reason it’s a relentless is the inside knowledge of what’s on its way .A possible default on the revenue number potentially a capital Regig which would inevitably lead to massive dilution. The only certainty is we will get the usual painful news